June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Retinal immune activity can be visualized in non-human primate in vivo using offset aperture AOSLO
Author Affiliations & Notes
  • Drew Ashbery
    University of Rochester Medical Center, Rochester, New York, United States
    Center for Visual Science, Rochester, New York, United States
  • Hector C Baez
    Center for Visual Science, Rochester, New York, United States
    Biomedical Engineering, University of Rochester, Rochester, New York, United States
  • Rye E Kanarr
    Center for Visual Science, Rochester, New York, United States
  • Karteek Kunala
    Center for Visual Science, Rochester, New York, United States
  • Derek Power
    Center for Visual Science, Rochester, New York, United States
  • Jesse B Schallek
    Center for Visual Science, Rochester, New York, United States
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • Juliette E McGregor
    Center for Visual Science, Rochester, New York, United States
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • Footnotes
    Commercial Relationships   Drew Ashbery None; Hector Baez None; Rye Kanarr None; Karteek Kunala None; Derek Power None; Jesse Schallek Genentech, Code F (Financial Support), University of Rochester, Code P (Patent); Juliette McGregor None
  • Footnotes
    Support  Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under the AGI initiative NIH U24 EY033275 (McGregor), R01 EY028293 (Schallek), CVS core support from NIH P30 EY0001319. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Inst. of Health. Additional funding from Steven E. Feldon Scholarship from the Flaum Eye Institute (McGregor), Genentech Inc (Schallek) and an Unrestricted Grant to the University of Rochester Department of Ophthalmology, as well as a Career Advancement Award (Schallek) from Research to Prevent Blindness, New York, New York.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1039. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Drew Ashbery, Hector C Baez, Rye E Kanarr, Karteek Kunala, Derek Power, Jesse B Schallek, Juliette E McGregor; Retinal immune activity can be visualized in non-human primate in vivo using offset aperture AOSLO. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1039.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Non-human primates (NHPs) are critical to the pre-clinical development of human therapies for eye disease due to similarities in ocular anatomy, physiology, and immune function. The retinal immune response to injury, disease, and therapeutics is currently poorly understood. We employ phase contrast adaptive optics scanning light ophthalmoscopy (AOSLO) to visualize in vivo immune activity in the NHP retina on a cellular scale.

Methods : Offset aperture AOSLO recordings focused on retinal vascular layers were collected over six minute periods (4 Airy Disc (AD) pinhole, Offset laterally ~10 AD, 3mW, 1.5° x 1.5°, 730 nm pulsed laser) from five eyes of three NHPs over nine sessions. Imaging was performed in intact eyes and in the hour following high intensity ultrafast laser exposure (26.6 - 32.5 J/cm2, 730nm) to focally ablate the photoreceptor layer (PRL). Retinal videos were registered to correct for eye motion, averaged, and reviewed to identify putative immune cells. Counts and speeds of visible cells were determined manually. Metrics were computed in one eye, pre- and post-PRL ablation, by averaging data from 9-15 retinal locations 1.2 - 6.5° from laser exposure.

Results : In all imaging sessions, putative systemic immune cells were identified flowing within and adhering to the inner wall of retinal vessels. Immune cell behaviors characteristic of the extravasation cascade such as capture, rolling, and crawling were observed. Immune cell diameters were ~9 - 12 µm, consistent with literature, and 107 cells were observed in total. In one intact eye, an average of 5.5 ± 6 S.D. cells/mm of retinal vasculature was observed with crawling speeds ranging from 0.17 to 0.32 μm/s. In the first hour following PR ablation in the same eye, an average of 7.1 ± 8 S.D. cells/mm was observed with crawling speeds of 0.11 to 0.30 μm/s. Averaging all sessions and locations in this eye, immune cells were 5 fold more numerous in venules than arterioles (X2 (1, N = 25)=32.9, p < .0001). Vascular perfusion remained uninterrupted throughout imaging.

Conclusions : Immune cell activity within retinal vasculature can be visualized label free in living NHPs. This proof of concept study demonstrates that offset aperture AOSLO may serve to be a useful tool to assess the engagement of the systemic immune system in disease models and next-generation therapeutic interventions in NHP.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×